BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32703059)

  • 1. Evaluation of human papillomavirus self-collection offered by community health workers at home visits among under-screened women in Brazil.
    Pantano NP; Fregnani JH; Resende JC; Zeferino LC; Fonseca BO; Antoniazzi M; Oliveira CM; Sant'ana GDR; Longatto-Filho A
    J Med Screen; 2021 Jun; 28(2):163-168. PubMed ID: 32703059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
    Lofters A; Devotta K; Prakash V; Vahabi M
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 6. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
    Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
    BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina.
    Arrossi S; Paolino M; Thouyaret L; Laudi R; Campanera A
    Implement Sci; 2017 Feb; 12(1):17. PubMed ID: 28193227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial.
    Arrossi S; Thouyaret L; Herrero R; Campanera A; Magdaleno A; Cuberli M; Barletta P; Laudi R; Orellana L;
    Lancet Glob Health; 2015 Feb; 3(2):e85-94. PubMed ID: 25617202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model.
    Dutton T; Marjoram J; Burgess S; Montgomery L; Vail A; Callan N; Jacob S; Hawkes D; Saville M; Bailey J
    BMC Health Serv Res; 2020 May; 20(1):398. PubMed ID: 32393243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
    Buick C; Jembere N; Wang L; Kupets R
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
    Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
    Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
    Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening.
    Li J; Wu R; Qu X; Huang X; Li L; Lin Z; Zhang Z; Deng J; Liu R; Zhao X; Zhang S; Lin B; An R; Zhao C; Li M; Zhao Y; Wei L
    Front Public Health; 2022; 10():938272. PubMed ID: 36420004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
    Coldman A; van Niekerk D; Smith L; Ogilvie G
    J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
    Fokom Domgue J; Cunningham SA; Yu RK; Shete S
    Ann Epidemiol; 2019 Aug; 36():40-47. PubMed ID: 31320153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
    Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
    J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cytopathological screening results and risk factors of women who underwent Papanicolaou test in a maternity school in Fortaleza, Ceará, Brazil.
    Tavares MDC; Nicol AF; Yokobatake ER; Melo MML; Vitoriano BF; Carvalho-Costa FA; Martinelli KG; de Paula VS
    Cytopathology; 2020 Nov; 31(6):586-592. PubMed ID: 32632990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.
    Ma'som M; Bhoo-Pathy N; Nasir NH; Bellinson J; Subramaniam S; Ma Y; Yap SH; Goh PP; Gravitt P; Woo YL
    BMJ Open; 2016 Aug; 6(8):e011022. PubMed ID: 27491667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.